Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) renal cell carcinoma (ccRCC) patients with different clinical response to ICIs (nivolumab) and treatment
-eclampsia/eclampsia,
renal failure, cytotoxic agents and autoimmune conditions. The mechanism underlying PRES is not certain